News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Research Is The Reason Nicole Seagriff had options to treat her breast cancer – The Breast Cancer Research Foundation
The Breast Cancer Research Foundation
Nov 13, 2024, 08:36

Research Is The Reason Nicole Seagriff had options to treat her breast cancer – The Breast Cancer Research Foundation

“As a two-time breast cancer survivor and president of The Pink Agenda, Nicole Seagriff has seen the power of research firsthand.

Research Is The Reason she had options to treat her breast cancer and can now raise awareness and funds for research to investigate the disease in younger women. 

Click here to read her story.”

Research Is The Reason Nicole Seagriff had options to treat her breast cancer - The Breast Cancer Research Foundation

Breast Cancer cancer Nicole Seagriff OncoDaily Oncology The Breast Cancer Research Foundation The Pink Agenda
Special Coverage
Insight
Dec 22, 2024, 11:22
Omar Alhalabi: Antiangiogenesis and immune checkpoint blockade in urothelial cancer
Blog
Dec 22, 2024, 10:51
Gemma Peters: Heading into 2025 with hope
Science
Dec 22, 2024, 10:44
5 papers about Lung Cancer suggested by Stephen Liu
Science
Dec 22, 2024, 10:15
Dégi László Csaba: Thrilled to announce the new Lancet Oncology Policy Review analyzing NCCPs worldwide
Science
Dec 22, 2024, 10:13
Denis Horgan: Delayed Access to Personalized Medicine in the EU - What’s the Cost to Patients?
Blog
Dec 22, 2024, 10:12
Emad Shash: Honor to be among the newly elected council of the Egyptian Cancer Society
Science
Dec 22, 2024, 10:03
María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy
Science
Dec 22, 2024, 10:00
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Science
Dec 22, 2024, 09:59
CDK4/6 inhibitors: mechanisms of resistance and where to find them - Lorenzo Gerratana
Blog
Dec 22, 2024, 09:53
India's Oncology Testing Market Projected to Grow at 2% CAGR Through 2033: GlobalData
Dialogues
Dec 22, 2024, 09:40
Botensilimab: A Novel Anti-CTLA- 4 Therapy Effectively Treats Refractory Colorectal Cancers
Dialogues
Dec 22, 2024, 09:04
Carlos Rodriguez-Galindo: The Man Who Will Cure the World